sorafenib

Poland

Drugs containing this active substance

  • SORAFENIB MYLAN

    It is used in the treatment of liver cancer and in the treatment of advanced kidney cancer in patients for whom standard therapy has not been effective or is not indicated.

    Form: tablets, film-coated

    Active substance Dosage
    sorafenib 200 mg

    ATC: L01EX02

    Manufacturer: PharOS Mt Ltd

  • SORAFENIB PHARMASCIENCE

    The medicine is used to treat liver cancer and advanced kidney cancer in patients for whom standard therapy has not been effective or was not indicated.

    Form: tablets, film-coated

    Active substance Dosage
    sorafenib 200 mg

    ATC: L01EX02

    Manufacturer: PharOS Mt Ltd